European Food Research and Technology

, Volume 234, Issue 3, pp 369–380

Health-promoting potential of edible macromycetes under special consideration of polysaccharides: a review

Review Paper

Abstract

Edible macromycetes for ages have been used by humans, not only as a source of food, but medicinal resources as well; however, this happened first of all in the civilizations of the East. In recent years, they have become subjects of numerous scientific studies in Europe and United States. It was shown that they constitute a rich source of bioactive compounds exhibiting antitumor, hypocholesterolemic, immunosuppressive, antioxidant, antimicrobial and anti-inflammatory properties. These compounds include non-starch polysaccharides, polysaccharide–protein and polysaccharide–peptide complexes, ribonucleases, proteases and lectins. Mushrooms also accumulate many secondary metabolites, that is, polyphenols, polyketides, terpenes and steroids. Most of the above-mentioned compounds exhibit a clinical potential. In this article, the health-promoting potential of mushroom polisaccharides was characterized. The special attention was paid on their antitumor, antiatherogenic and prebiotic activities.

Keywords

Edible mushrooms Polysaccharides Bioactivity Health-promoting potential 

References

  1. 1.
    Aida FMNA, Shuhaimi M, Yazid M, Maaruf AG (2009) Mushroom as a potential source of prebiotics: a review. Trends Food Sci Technol 20:567–575CrossRefGoogle Scholar
  2. 2.
    Alarcón J, Aguila S, Arancibia-Avila P, Fuentes O, Zamorano-Ponce E, Hernández M (2003) Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Z Naturforsch C 58:62–64Google Scholar
  3. 3.
    Augustín J, Jaworska G, Dandár A, Cejpek K (2007) Oyster mushroom (Pleurotus ostreatus) as a source of beta-D-glucanes. Food Sci Technol Qual 6(55):170–176Google Scholar
  4. 4.
    Awad AB, Smith AJ, Fink CS (2001) Plant sterols regulate rat vascular smooth muscle cell growth and prostacyclin release in culture. Prostaglandins Leukot Essent Fat Acids 64(6):323–330CrossRefGoogle Scholar
  5. 5.
    Barros L, Baptista P, Estevinho LM, Ferreira ICFR (2007) Bioactive properties of medicinal mushroom Leucopaxillus giganteus mycelium obtained in the presence of different nitrogen sources. Food Chem 105:179–186CrossRefGoogle Scholar
  6. 6.
    Bernaś E, Jaworska G, Lisiewska Z (2006) Edible mushrooms as a source of valuable nutritive constituents. Acta Sci Pol Technol Aliment 5:5–20Google Scholar
  7. 7.
    Bobek P, Galbavy S (2001) Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 58:164–168Google Scholar
  8. 8.
    Bobek P, Ozdin L, Kuniak L (1995) Effect of oyster mushroom and isolated β-glucan on lipid peroxidation and on the activities of antioxidant enzymes in rats fed the cholesterol diet. Nutr Biochem 8:469–471CrossRefGoogle Scholar
  9. 9.
    Bobek P, Ozdin L, Kuniak L (1996) Effect of oyster mushroom (Pleurotus ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercho-lesterolemic rat. Nahrung 40(4):222–224CrossRefGoogle Scholar
  10. 10.
    Bobek P, Ozdin L, Kuniak L (1997) Effect of oyster mushroom and isolated β-glukan on lipid peroxidation and on the activities of antioxidative enzymem in rats fed the cholesterol diet. J Nutr Biochem 8(8):469–471CrossRefGoogle Scholar
  11. 11.
    Braaksma A, Schaap DJ (1996) Protein analysis of the common mushroom Agaricus bisporus. Postharv Biol Technol 7:119–127CrossRefGoogle Scholar
  12. 12.
    Carbonero ER, Gracher AH, Smiderle FR, Rosado FR, Sassaki GL, Gorin PAJ, Iacomini M (2006) A β-glucan from the fruit bodies of edible mushrooms Pleurotus eryngii and Pleurotus ostreatoroseus. Carbohydr Polym 66:252–257CrossRefGoogle Scholar
  13. 13.
    Chakraborty I, Mondal S, Pramanik M, Rout D, Islam SS (2004) Structural investigation of a water-soluble glucan from an edible mushroom Astraeus hygrometricus. Carbohydr Res 339:2249–2254CrossRefGoogle Scholar
  14. 14.
    Chen J, Seviour R (2007) Medicinal importance of fungal beta-(1 → 3), (1 → 6)-glucans. Mycol Res 111(6):635–652CrossRefGoogle Scholar
  15. 15.
    Cheng JJ, Lin CY, Lur HS, Chen HP, Lu MK (2008) Properties and biological functions of polysaccharides and ethanolic extracts isolated from medicinal fungus, Fomitopsis pinicola. Process Biochem 43:829–834CrossRefGoogle Scholar
  16. 16.
    Cheung PCK (1998) Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. J Nutr 128(9):1512–1516Google Scholar
  17. 17.
    Cheung PCK (2008) In: Cheung PCK (ed) Mushrooms as functional foods. Wiley, HobokenGoogle Scholar
  18. 18.
    Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarkoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature 222:687–688CrossRefGoogle Scholar
  19. 19.
    COUNCIL REGULATION (EC) No 733/2008 of 15 July 2008 on the conditions governing imports of agricultural products originating in third countries following the accident at the Chernobyl nuclear power stationGoogle Scholar
  20. 20.
    Cui J, Chisti Y (2003) Polysaccharopeptides of Coriolus versicolor: physiological activity, uses and production. Biotechnol Adv 21:109–122CrossRefGoogle Scholar
  21. 21.
    De Oliveira AJB, Goncalves RAC, Chierrito TPC, dos Santos MM, de Souza LM, Gorin PAJ, Sassaki GL, Iacomini M (2011) Structure and degree of polymerization of fructooligosaccharides present in roots and leaves of Stevia rebaudiana (Bert.) Bertoni. Food Chem 129:305–311CrossRefGoogle Scholar
  22. 22.
    Dietschy JM, Turley SD, Spady DK (1993) Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, includ-ing humans. J Lipid Res 34:1637–1659Google Scholar
  23. 23.
    Dissanayake DP, Abeytunga DTU, Vasudewa NS, Ratnasooriya WD (2009) Inhibition of lipid peroxidation by extracts of Pleurotus ostreatus. Pharmacogn Mag 5(19):266–271Google Scholar
  24. 24.
    Doyon M, Labrecque JA (2008) Functional foods: a conceptual definition. Br Food J 110(11):1133–1149CrossRefGoogle Scholar
  25. 25.
    Falch BH, Espevik T, Ryan L, Stokke BT (2000) The cytokine stimulating activity of (1 → 3)-beta-d-glucans is dependent on the triple helix conformation. Carbohydr Res 329(3):587–596CrossRefGoogle Scholar
  26. 26.
    Florkowska A, Krygier K (2004) Application of indigestible oligosaccharides in foodstuffs. Przem Spoż 5:44–46Google Scholar
  27. 27.
    Førland DT, Johnson E, Tryggestad AMA, Lyberg T, Hetland G (2010) An extract based on the medicinal mushroom Agaricus blazei Murillc stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine 49:245–250CrossRefGoogle Scholar
  28. 28.
    Frank JA, Xiao R, Shanggong Y, Ferguson M, Hennings LJ, Simpson PM, Ronis MJJ, Fang N, Badger TM, Simmen FA (2006) Effect of Shiitake mushroom dose on colon tumorigenesis in azoxymethane-treated male Sprague-Dawley rats. Nutr Res 26(3):138–145CrossRefGoogle Scholar
  29. 29.
    Franz G (1989) Polysaccharides in pharmacy: current applications and future concepts. Planta Med 55:493–497CrossRefGoogle Scholar
  30. 30.
    Freimund S, Sauter M, Käppeli O, Dutler H (2003) A new non-degrading isolation process for 1,3-β-d-glucan of high purity from baker’s yeast Saccharomyces cerevisiae. Carbohydr Polym 54:159–171CrossRefGoogle Scholar
  31. 31.
    Furlani RPZ, Godoy HT (2008) Vitamins B1 and B2 contents in cultivated mushrooms. Food Chem 106:816–819CrossRefGoogle Scholar
  32. 32.
    Gern RMM, Wisbeck E, Rampinelli JR, Ninow JL, Furlan SA (2008) Alternative medium for production of Pleurotus ostreatus biomass and potential antitumor polysaccharides. Bioresour Technol 99:76–82CrossRefGoogle Scholar
  33. 33.
    Giatromanolaki A, Koukourakis M, O’Byrne K, Fox S, Whitehouse R, Talbot D, Harris AL, Gatter KC (1996) Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179:80–88CrossRefGoogle Scholar
  34. 34.
    Gibson G, Probert HM, Van Loo J, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:259–275CrossRefGoogle Scholar
  35. 35.
    Guillamón E, García-Lafuente A, Lozano M, D’Arrigo M, Rostagno MA, Villares A et al (2010) Edible mushroom: their roles in the prevention of cardiovascular diseases. Fitoterapia 81:715–723CrossRefGoogle Scholar
  36. 36.
    Gunde-Cimerman N, Plemenitaš A, Cimerman A (2006) Pleurotus fungi produce mevinolin, an inhibitor of HMG CoA reductase. FEMS Microbiol Lett 113(3):333–337CrossRefGoogle Scholar
  37. 37.
    Hasegawa T, Fujisawa T, Haraguchi S, Numata M, Karinaga R, Kimura T, Okumura S, Sakurai K, Shinkai S (2005) Schizophyllan-folate conjugate as a new non-cytotoxic and cancer-targeted antisense carrier. Bioorg Med Chem Lett 15:327–330CrossRefGoogle Scholar
  38. 38.
    Hearst R, Nelson D, McCollum G, Millar BC, Maeda Y, Goldsmith CE, Rooney PJ, Loughrey A, Rao JR, Moore JE (2009) An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) nad Oyster (Pleurotus ostreatus) mushrooms. Complement Ther Clin Pract 15(1):5–7CrossRefGoogle Scholar
  39. 39.
    Hirasawa M, Shouji NNT, Fukushima K, Takada K (1999) Three kinds of bacterial substances from Lentinus edodes (Berk.) Sing. (shiitake, an edible mushroom). Int J Antimicrob Agents 11(2):151–157CrossRefGoogle Scholar
  40. 40.
    Ho J, Konerding M, Gaumann A, Groth M, Liu W (2004) Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci 75:1343–1356CrossRefGoogle Scholar
  41. 41.
    Hobbs C (2000) Medicinal values of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A literature review. Int J Med Mushrooms 2:287–297Google Scholar
  42. 42.
    Hou XJ, Chen W (2008) Optimization of extraction process of crude polysaccharides from wild edible BaChu mushroom polysaccharides and preparation of compound beverage. Carbohydr Polym 73:67–74Google Scholar
  43. 43.
    Israilides C, Kletsas D, Arapoglu D, Philippossis A, Pratsinis H, Ebringerova A, Hribalova F, Haarding SE (2008) In vitro cytostatic and immonomodulatory properties of the of the medicinal mushroom Lentinula edodes. Phytomedicine 15:512–519CrossRefGoogle Scholar
  44. 44.
    Ji Z, Tang O, Zhang J, Yang Y, Jia W, Pan Y (2007) Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharm 112:445–450CrossRefGoogle Scholar
  45. 45.
    Kalač P (2001) A review of edible mushroom radioactivity. Food Chem 75:29–35CrossRefGoogle Scholar
  46. 46.
    Kalač P (2010) Trace element contents in European species of wild growing edible mushrooms: a review for the period 2000–2009. Food Chem 122:2–15CrossRefGoogle Scholar
  47. 47.
    Kędziora S, Słotwiński R (2009) Molecular mechanisms associated with recognition of pathogens of innate immunity. Postepy Hig Med Dosw 63:30–38Google Scholar
  48. 48.
    Kitzberger CSG, Smânia JA, Pedrosa RC, Ferreira SRS (2007) Antioxidant and antimicrobial activities of shiitake (Lentinula edodes) extracts obtained by organic solvents and supercritical fluids. J Food Eng 80:631–638CrossRefGoogle Scholar
  49. 49.
    Knorr D (2006) Functional properties of chitin and chitosan. J Food Sci 47(2):593–595CrossRefGoogle Scholar
  50. 50.
    Kodama N, Komuta K, Sakai N, Nanba H (2002) Effect of d-fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull 25:1647–1650CrossRefGoogle Scholar
  51. 51.
    Kumari M, Survase SA, Singhal RS (2008) Production of schizophyllan using Schizophyllum commune NRCM. Bioresour Technol 99:1036–1104CrossRefGoogle Scholar
  52. 52.
    Kurashige S, Akuzawa Y, Endo F (1997) Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol 19:175–183CrossRefGoogle Scholar
  53. 53.
    Lai CKM, Wong KH, Cheung PCK (2008) Antiproliferative effects of sclerotial polysaccharides from Polyporus rhinocerus Cooke (Aphyllophoromycetideae) on different kinds of leukemic cells. Int J Med Mushrooms 10:255–264CrossRefGoogle Scholar
  54. 54.
    Li H, Zhang M, Ma G (2010) Hypolipidemic effect of the polysaccharide from Pholiota nameko. Nutrition 26(5):556–562CrossRefGoogle Scholar
  55. 55.
    Libudzisz Z (2006) In: Gawęcki J, Libudzisz Z (eds) Microorganisms in food and nutrition. Wydawnictwo Akademii Rolniczej im. Augusta Cieszkowskiego w PoznaniuGoogle Scholar
  56. 56.
    Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VLW, Li FP, Rao JY (2004) Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vivo. Cancer Lett 216:9–20CrossRefGoogle Scholar
  57. 57.
    Manisseri C, Gudipati M (2010) Bioactive xylo-oligosaccharides from wheat bran soluble polysaccharides. LWT-Food Sci Technol 43:421–430CrossRefGoogle Scholar
  58. 58.
    Manzi P, Pizzoferrato L (2000) Beta-glucans in edible mushrooms. Food Chem 68:315–318CrossRefGoogle Scholar
  59. 59.
    Mao C-F, Hsu M-C, Hwang W-H (2007) Physicochemical characterization of grifolan: thixotropic properties and complex formation with Congo Red. Carbohydr Polym 68(3):502–510CrossRefGoogle Scholar
  60. 60.
    Matisoff G, Ketterer ME, Rosén K, Mietelski JW, Vitko LF, Persson H, Lokas E (2011) Downward migration of Chernobyl-derived radionuclides in soils in Poland and Sweden. Appl Geochem 26:105–115CrossRefGoogle Scholar
  61. 61.
    Mattila P, Suonpaä K, Piironen V (2000) Functional properties of edible mushroom. Nutrition 16(7/8):694–696CrossRefGoogle Scholar
  62. 62.
    Mayell M (2001) Maitake extracts and their therapeutic potential—a review. Altern Med Rev 6:48–60Google Scholar
  63. 63.
    Mietelski JW, Dubchak S, Błażej S, Anielska T, Turnau K (2010) 137Cs and 40K in fruiting bodies of different fungal species collected in a single forest in southern Poland. J Environ Radioact 101:706–711CrossRefGoogle Scholar
  64. 64.
    Mizuno T (1995) Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Food Rev Int 11:7–21Google Scholar
  65. 65.
    Muzzarelli RAA (1999) In: Jollies P, Muzzarelli RAA (eds) Chitin and chitinases. Birkhauser Verlag Basel, SwitzerlandGoogle Scholar
  66. 66.
    Ojansivu I, Ferreira CL, Salminen S (2011) Yacon, a new source of prebiotic oligosaccharides with a history of safe use. Trends Food Sci Technol 22:40–46CrossRefGoogle Scholar
  67. 67.
    Okamoto T, Kodoi R, Nonaka Y, Fukuda I, Hashimoto T, Kanazawa K, Mizuno M, Ashida H (2004) Lentinan from Shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. BioFactors 21:407–409Google Scholar
  68. 68.
    Petrovska BB (2001) Protein fraction in edible Macedonian mushrooms. Eur Food Res Technol 212:469–472CrossRefGoogle Scholar
  69. 69.
    Podymniak M (2005) On common agaric and other cultivated mushrooms. Hasło Ogrod 6:11–12Google Scholar
  70. 70.
    Preidis GA, Versalovic J (2009) Targeting the human microbiome with antibiotics, probiotics and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136(6):2015–2031CrossRefGoogle Scholar
  71. 71.
    Radzki W (2009) Health-promoting properties of mushrooms. Pieczarki 3:76–79Google Scholar
  72. 72.
    Rajewska J, Bałasińska B (2004) Biologically active compounds of edible mushrooms and their beneficial impact on health. Postepy Hig Med Dosw 58:352–357Google Scholar
  73. 73.
    Reguła J, Siwulski M (2007) Dried shiitake (Lentinulla edodes) and oyster (Pleurotus ostreatus) mushrooms as a good source of nutrient. Acta Sci Pol Technol Aliment 6(4):135–142Google Scholar
  74. 74.
    Ribeiro B, Guedes de Pinho P, Andrade PB, Baptista P, Valentão P (2009) Fatty acid composition of wild edible mushrooms species: a comparative study. Microchem J 93:29–35CrossRefGoogle Scholar
  75. 75.
    Rop O, Mlcek J, Jurikova T (2009) Beta-glucans in higher fungi and their health effect. Nutr Rev 67(11):624–631CrossRefGoogle Scholar
  76. 76.
    Ross GD, Vĕtvička V, Yan J, Xia Y, Vĕtvičková J (1999) Therapeutic intervention with complement and β-glucan in cancer. Immunopharmacology 42:61–74CrossRefGoogle Scholar
  77. 77.
    Sabater-Molina M, Larqué E, Torrella F, Zamora S (2009) Dietary frictooligosaccharides and potential benefits on health. J Physiol Biochem 65(3):315–328CrossRefGoogle Scholar
  78. 78.
    Sarangi I, Ghosh D, Bhutia SK, Mallick SK, Maiti TK (2006) Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int Immunopharmacol 6:1287–1297CrossRefGoogle Scholar
  79. 79.
    Sarikurkcu C, Tepe B, Semiz DK, Solak MH (2010) Evaluation of metal concentration and antioxidant activity of three edible mushrooms from Mulga, Turkey. Food Chem Toxicol 48:1230–1233CrossRefGoogle Scholar
  80. 80.
    Schmid J, Meyer V, Sieber V (2011) Scleroglucan: biosynthesis, production and application of a versatile hydrocolloid. Appl Microbiol Biotechnol 91:937–947CrossRefGoogle Scholar
  81. 81.
    Shamtsyan M, Konusova V, Maximova Y, Goloshchev A, Panchenko A, Simbirtsev A (2004) Immunomodulating and anti-tumor action of extracts of several mushrooms. J Biotechnol 113:77–83CrossRefGoogle Scholar
  82. 82.
    Sochocka M (2008) Recognition of pathogens by innate immunity. Postepy Hig Med Dosw 62:676–687Google Scholar
  83. 83.
    Suárez ER, Bugden SM, Kai FB, Kralovec KA, Noseda MD, Barrow CJ, Grindley TB (2008) First isolation and structural determination of cyclic β-(1 → 2)-glucans from an alga, Chlorella pyrenoidosa. Carbohydr Res 343:2623–2633CrossRefGoogle Scholar
  84. 84.
    Suga T, Shiio T, Maeda YY, Chihara G (1984) Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 44:5132–5137Google Scholar
  85. 85.
    Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Fukuda N, Hasegawa Y (1980) A novel use of chitosan as a hypocholesterolemic agent in rats. Am J Clin Nutr 33:787–789Google Scholar
  86. 86.
    Suzuki T, Ohno N, Saito K, Yadomae T (1992) Activation of the complement-system by 1,3-beta-d-glucans having different degrees of branching and different ultrastructures. J Pharmacobiodyn 15:277–285CrossRefGoogle Scholar
  87. 87.
    Synytsya A, Mičková A, Synytsya A, Jablonsky I, Spěváček J, Erban V, Kováříková E, Čopíková J (2009) Glucans from fruit bodies of cultivated mushrooms Pleurotus eryngii: structure and potential prebiotic activity. Carbohydr Polym 76:548–556CrossRefGoogle Scholar
  88. 88.
    Tao Y, Zhang L, Cheun PCK (2006) Physicochemical properties and antitumor activities of water-soluble native and sulfated hyperbranched mushroom polysaccharides. Carbohydr Res 341:2261–2269CrossRefGoogle Scholar
  89. 89.
    Thomet U, Vogel E, Krähenbühl U (1999) The uptake of cadmium and zinc by mycelia and their accumulation in mycelia and fruiting bodies of edible mushrooms. Eur Food Res Technol 209:317–324CrossRefGoogle Scholar
  90. 90.
    Tong H, Xia F, Feng K, Sun G, Gao X, Sun L, Jiang R, Tian D, Sun X (2009) Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus. Bioresour Technol 100:1682–1686CrossRefGoogle Scholar
  91. 91.
    Turkoglu A, Duru ME, Mercan N, Kivrak I, Gezer K (2007) Antioxidant and antimicrobial activities of Leatiporus sulphureus (Bull.) Murrill. Food Chem 101:267–273CrossRefGoogle Scholar
  92. 92.
    Vetter J (2004) Arsenic content of some edible mushroom species. Eur Food Res Technol 219:71–74CrossRefGoogle Scholar
  93. 93.
    Vinichuk M, Taylor AFS, Rosén K, Johanson KJ (2010) Accumulation of potassium, rubidium and caesium (133Cs and 137Cs) in various fractions of soil and fungi in a Swedish forest. Sci Total Environ 408:2543–2548CrossRefGoogle Scholar
  94. 94.
    Wang H, Ng TB (2004) Erygin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii. Peptides 25:1–5CrossRefGoogle Scholar
  95. 95.
    Wang X, Zhang L (2009) Physicochemical properties and antitumor activities for sulfated derivatives of lentinan. Carbohydr Res 344:2209–2216CrossRefGoogle Scholar
  96. 96.
    Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258–274CrossRefGoogle Scholar
  97. 97.
    Wasser SP (2011) Current finding, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 89:1323–1332CrossRefGoogle Scholar
  98. 98.
    Wichienchot S, Jatupornpipat M, Rastall RA (2010) Oligosaccharides of pitaya (dragon fruit) flesh and their prebiotic properties. Food Chem 120:850–857CrossRefGoogle Scholar
  99. 99.
    Wong KH, Lai CKM, Cheung PCK (2011) Immunomodulatory activities of mushroom sclerotal polysaccharides. Food Hydrocoll 25:150–158CrossRefGoogle Scholar
  100. 100.
    Woźniak W, Gapiński M (2009) Biologically active compounds in mushrooms. Pieczarki 3:79–82Google Scholar
  101. 101.
    Yaltirak T, Aslim B, Ozturk S, Alli H (2009) Antimicrobial and antioxidant activities of Russula delica Fr. Food Chem Toxicol 47:2052–2056CrossRefGoogle Scholar
  102. 102.
    Yu Z, Ming G, Kiping W, Zhixiang C, Liquan D, Jingyu L, Fang Z (2010) Structure, chain, conformation and antitumor activity of novel polysaccharide from Lentinus edodes. Fitoterapia 81:1163–1170CrossRefGoogle Scholar
  103. 103.
    Zhang J, Liu J, Li L, Xia W (2008) Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets. Nutr Res 28(6):383–390CrossRefGoogle Scholar
  104. 104.
    Zhang J, Tang Q, Zhou C, Jia W, Silva LD, Nguyen LD, Reutter W, Fan H (2010) GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumor activity by increasing both humoral and cellular immune response. Life Sci 87:628–637CrossRefGoogle Scholar
  105. 105.
    Zhang J, Tang Q, Zimmerman-Kordmann M, Reutter W, Fan H (2002) Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci 71:623–638CrossRefGoogle Scholar
  106. 106.
    Zhang L, Li X, Xu X, Zeng F (2005) Correlation between antitumor activity. Molecular weight, and conformation of lentinan. Carbohydr Res 340:1515–1521CrossRefGoogle Scholar
  107. 107.
    Zhang M, Cui SW, Cheung PCK, Wang Q (2007) Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 18:4–19CrossRefGoogle Scholar
  108. 108.
    Zhang M, Zhang L, Cheung PCK, Ooi VEC (2003) Molecular weight and anti-tumor activity of the water-soluble polysaccharides isolated by hot water and ultrasonic treatment from the sclerotia and mycelia of Pleurotus tuber-regium. Carbohydr Polym 56:123–128CrossRefGoogle Scholar
  109. 109.
    Zhang Y, Li S, Wang X, Zhang L, Cheung PCK (2011) Advances in letinan: Isolation, structure, chain conformation and bioactivities. Food Hydrocoll 25:196–206CrossRefGoogle Scholar
  110. 110.
    Zhao L, Dong Y, Chen G, Hu Q (2010) Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr Polym 80:783–789CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Institute of Technology of Plant Origin FoodPoznan University of Life SciencesPoznanPoland
  2. 2.Department of Human Nutrition HygienePoznan University of Life SciencesPoznanPoland

Personalised recommendations